ArticleFrontiers in oncology2023

Transcriptional signature of early cisplatin drug-tolerant persister cells in lung adenocarcinoma.

Rodolfo Chavez-Dominguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.